Log In
Print this Print this

heparin plus DNase

  Manage Alerts
Collapse Summary General Information
Company Ockham Biotech Ltd.
DescriptionInhaled heparin plus Dnase
Molecular Target
Mechanism of Action 
Therapeutic ModalityMacromolecule: Polysaccharide
Latest Stage of DevelopmentPreclinical
Standard IndicationCystic fibrosis (CF)
Indication DetailsTreat cystic fibrosis (CF)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today